Gregorian S K, Battisto J R
Department of Chemistry, Cleveland State University, Ohio 44115.
Cancer Immunol Immunother. 1990;31(6):325-34. doi: 10.1007/BF01741403.
Four cell-mediated immunological responses related to tumor elimination have been examined in mice injected with a transplantable renal cell carcinoma (Renca). Lymphokine-activated killer (LAK) cells generated in vitro from spleen cells of normal mice were capable of attacking Renca, EL-4, P815 and YAC-1 targets, but those from mice bearing Renca for 3 weeks could not. Natural killer activity, stimulated in vivo by administering poly(I) poly(C), was less than 50% of normal in Renca-bearing hosts. In addition, development of cytotoxic T lymphocytes to allogeneic targets was markedly inhibited in mice possessing the renal tumor. Finally, the delayed hypersensitivity response to a dermally applied hapten was approximately 70% less than normal in tumor-bearing mice, no matter whether the tumor existed subcutaneously or intrarenally. A kinetic study of the development of non-responsiveness using the LAK assay showed onset of poor response at 1 week, which became maximal within 3 weeks following receipt of tumor subcutaneously. The immunological depression was seen to be attributable in part to suppressor cells present among spleen cells but not bone marrow cells of tumor-bearing hosts. The suppressor cells prevented in vitro LAK generation by normal spleen cells and, when adoptively transferred to normal mice, they inhibited natural killer stimulation and delayed hypersensitivity generation. Another source of immunological down-regulation was provided by Renca cells themselves. Incorporation of Renca cells that had been X-irradiated with 30,000 rad into cultures of normal and Renca-derived splenic cells suppressed replication of both almost completely. Furthermore, the presence of X-irradiated Renca cells in cultures of normal spleen cells prevented development of LAK cells. Thus, the suppression seen in Renca-bearing mice derives from multiple sources and whether each is in any way related to the other has been discussed. Identification of the phenotypes of cells responsible for the lymphoid cell-mediated suppression and examination of its elimination are communicated in the companion paper.
在注射了可移植肾细胞癌(Renca)的小鼠中,研究了与肿瘤消除相关的四种细胞介导的免疫反应。从正常小鼠脾细胞体外产生的淋巴因子激活的杀伤(LAK)细胞能够攻击Renca、EL-4、P815和YAC-1靶细胞,但来自携带Renca 3周的小鼠的LAK细胞则不能。通过给予聚肌苷酸-聚胞苷酸(poly(I) poly(C))在体内刺激的自然杀伤活性,在携带Renca的宿主中不到正常水平的50%。此外,在患有肾肿瘤的小鼠中,针对同种异体靶细胞的细胞毒性T淋巴细胞的发育受到明显抑制。最后,无论肿瘤是皮下还是肾内存在,荷瘤小鼠对皮肤应用半抗原的迟发型超敏反应比正常情况减少约70%。使用LAK测定法对无反应性发展的动力学研究表明,在皮下接种肿瘤后1周开始出现反应不良,在3周内达到最大程度。免疫抑制部分归因于荷瘤宿主脾细胞而非骨髓细胞中存在的抑制细胞。这些抑制细胞阻止正常脾细胞体外产生LAK细胞,并且当将它们过继转移到正常小鼠时,它们抑制自然杀伤刺激和迟发型超敏反应的产生。免疫下调的另一个来源是Renca细胞本身。将用30000拉德X射线照射过的Renca细胞加入正常和源自Renca的脾细胞培养物中,几乎完全抑制了两者的复制。此外,正常脾细胞培养物中存在经X射线照射的Renca细胞会阻止LAK细胞的发育。因此,在携带Renca的小鼠中看到的抑制来自多个来源,并且已经讨论了它们彼此之间是否以任何方式相关。在配套论文中交流了负责淋巴细胞介导的抑制的细胞表型鉴定及其消除的研究。